139 related articles for article (PubMed ID: 14648661)
1. Altered expression of the septin gene, SEPT9, in ovarian neoplasia.
Burrows JF; Chanduloy S; McIlhatton MA; Nagar H; Yeates K; Donaghy P; Price J; Godwin AK; Johnston PG; Russell SE
J Pathol; 2003 Dec; 201(4):581-8. PubMed ID: 14648661
[TBL] [Abstract][Full Text] [Related]
2. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis.
Scott M; McCluggage WG; Hillan KJ; Hall PA; Russell SE
Int J Cancer; 2006 Mar; 118(5):1325-9. PubMed ID: 16161048
[TBL] [Abstract][Full Text] [Related]
3. Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors.
Kalikin LM; Sims HL; Petty EM
Genomics; 2000 Jan; 63(2):165-72. PubMed ID: 10673329
[TBL] [Abstract][Full Text] [Related]
4. Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.
Russell SE; McIlhatton MA; Burrows JF; Donaghy PG; Chanduloy S; Petty EM; Kalikin LM; Church SW; McIlroy S; Harkin DP; Keilty GW; Cranston AN; Weissenbach J; Hickey I; Johnston PG
Cancer Res; 2000 Sep; 60(17):4729-34. PubMed ID: 10987277
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.
Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
[TBL] [Abstract][Full Text] [Related]
6. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.
Montagna C; Lyu MS; Hunter K; Lukes L; Lowther W; Reppert T; Hissong B; Weaver Z; Ried T
Cancer Res; 2003 May; 63(9):2179-87. PubMed ID: 12727837
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
Shridhar V; Bible KC; Staub J; Avula R; Lee YK; Kalli K; Huang H; Hartmann LC; Kaufmann SH; Smith DI
Cancer Res; 2001 May; 61(10):4258-65. PubMed ID: 11358853
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
9. Properties of SEPT9 isoforms and the requirement for GTP binding.
Robertson C; Church SW; Nagar HA; Price J; Hall PA; Russell SE
J Pathol; 2004 May; 203(1):519-27. PubMed ID: 15095474
[TBL] [Abstract][Full Text] [Related]
10. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3.
McIlhatton MA; Burrows JF; Donaghy PG; Chanduloy S; Johnston PG; Russell SE
Oncogene; 2001 Sep; 20(41):5930-9. PubMed ID: 11593400
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.
Santos J; Cerveira N; Bizarro S; Ribeiro FR; Correia C; Torres L; Lisboa S; Vieira J; Mariz JM; Norton L; Snijder S; Mellink CH; Buijs A; Shih LY; Strehl S; Micci F; Heim S; Teixeira MR
Leuk Res; 2010 May; 34(5):615-21. PubMed ID: 19748670
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
13. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours.
Scott M; Hyland PL; McGregor G; Hillan KJ; Russell SE; Hall PA
Oncogene; 2005 Jul; 24(29):4688-700. PubMed ID: 15782116
[TBL] [Abstract][Full Text] [Related]
14. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
15. Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.
Lee PS; Teaberry VS; Bland AE; Huang Z; Whitaker RS; Baba T; Fujii S; Secord AA; Berchuck A; Murphy SK
Int J Cancer; 2010 Mar; 126(6):1378-89. PubMed ID: 19642140
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.
Wojnarowicz PM; Provencher DM; Mes-Masson AM; Tonin PN
Int J Oncol; 2012 Jun; 40(6):1865-80. PubMed ID: 22344671
[TBL] [Abstract][Full Text] [Related]
17. Translational control of SEPT9 isoforms is perturbed in disease.
McDade SS; Hall PA; Russell SE
Hum Mol Genet; 2007 Apr; 16(7):742-52. PubMed ID: 17468182
[TBL] [Abstract][Full Text] [Related]
18. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
He X; Ee PL; Coon JS; Beck WT
Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
[TBL] [Abstract][Full Text] [Related]
20. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
